Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach

British Journal of Pharmacology

Volumn 128, Issue 8, 1999, Pages 1659-1666

  Maricic, Nenad ^a   Ehrlich, Karlheinz ^a   Gretzer, Britta ^a   Schuligoi, Rufina ^b   Respondek, Michael ^a   Peskar, Brigitta M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cyclo oxygenase 1; Cyclo oxygenase 2; Dexamethasone; DFU; Gastric mucosal damage; Indomethacin; Ischaemia reperfusion; NS 398

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2; 3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH DISEASE; STOMACH MUCOSA;

EID: 0033407470     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702966     Document Type: Article

References (51)

1. BEICHE, F., BRUNE, K., GEISSLINGER, G. & GOPPELT-STRUEBE, M. (1998). Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm. Res., 47, 482-487.
2. BISHOP-BAILEY, D., BURKE-GAFFNEY, A., HELLEWELL, P.G., PEPPER, J.R. & MITCHELL, J.A. (1998). Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 249, 44-47.
3. CARLSSON, I., SOLLEVI, A. & WENNMALM, A. (1987). The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia. J. Physiol., 389, 147-161.
4. CARLSSON, I. & WENNMALM, A. (1983). Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearm. Prostaglandins, 26, 241-252.
5. DAVIES, N.M., SHARKEY, K.A., ASFAHA, S., MACNAUGHTON, W.K. & WALLACE, J.L. (1997). Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment. Pharmacol. Ther., 11, 1101-1108.
6. DUBOIS, R.N., ABRAMSON, S.B., CROFFORD, L., GUPTA, R.A., SIMON, L.S., VAN DE PUTTE, L.B.A. & LIPSKY, P.E. (1998). Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
7. EBERHART, C.E., COFFEY, R.J., RADHIKA, A., GIARDIELLO, F.M., FERRENBACH, S. & DUBOIS, R.N. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
8. EHRLICH, K. PLATE, S., STROFF, T., GRETZER, B., RESPONDEK, M. & PESKAR, B.M. (1998). Peptidergic and cholinergic neurons and mediators in peptone-induced gastroprotection: role of cyclooxygenase-2. Am. J. Physiol., 274, G955-G964.
9. FERRAZ, J.G.P., SHARKEY, K.A., REUTER, B.K., ASFAHA, S., TIGLEY, A.W., BROWN, M.L., MCKNIGHT, W. & WALLACE, J.L. (1997). Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology, 113, 195-204.
10. FUTAKI, N., TAKAHASHI, S., YOKOYAMA, M., ARAI, I., HIGUCHI, S. & OTOMO, S. (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.
11. FUTAKI, N., YOSHIKAWA, K. HAMASAKA, Y., ARAI, I., HIGUCHI, S., IISUKA, H. & OTOMO, S. (1993). NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol., 24, 105-110.
12. GRETZER, B., EHRLICH, K., MARICIC, N., LAMBRECHT, N., RESPONDEK, M. & PESKAR, B.M. (1998). Selective cyclooxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br. J. Pharmacol., 123, 927-935.
13. GRYGLEWSKI, R.J., SZCZEKLIK, A. & WANDZILAK, M. (1987). The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucylphenylalanine. Biochem. Pharmacol., 36, 4209-4213.
14. 4 release from activated neutrophils. Proc. Natl. Acad. Sci. U.S.A., 80, 4349-4353.
15. HANIF, R., PITTAS, A., FENG, Y., KOUTSOS, M.I., QIAO, L., STAIANO-COICO, L., SHIFF, S.I. & RIGAS, B. (1996). Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52, 237-245.
16. HAWKEY, C.J. (1999). COX-2 inhibitors. Lancet, 353, 307-314.
17. HERNANDEZ, L.A., GRISHAM, M.B., TWOHIG, B., ARFORS, K.E., HARLAN, J.M. & GRANGER, D.N. (1987). Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am. J. Physiol., 253, H699-H703.
18. HLA, T. & NEILSON, K. (1992). Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U.S.A., 89, 7384-7388.
19. IKEDA, H., SUZUKI, Y., SUZUKI, M., KOIKE, M., TAMURA, J., TONG, J., NOMURA, M. & ITOH, G. (1998). Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut, 42, 530-537.
20. ISEKI, S. (1995). Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem. J., 27, 323-328.
21. KAINOH, M., IMAI, R., UMETSU, T., HATTORI, M. & NISHIO, S. (1990). Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes. Biochem. Pharmacol., 39, 477-484.
22. KARGMAN, S., CHARLESON, S., CARTWRIGHT, M., FRANK, J., RIENDEAU, D., MANCINI, J., EVANS, J. & O'NEILL, G. (1996). Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111, 445-454.
23. KISHIMOTO, Y., WADA, K., NAKAMOTO, K., KAWASAKI, H. & HASEGAWA, J. (1998). Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats. Arch. Biochem. Biophys., 352, 153-157.
24. KUBES, P., IBBOTSON, G., RUSSELL, J., WALLACE, J.L. & GRANGER, D.N. (1990). Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol., 259, G300-G305.
25. KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W. & HERSCHMAN, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872.
26. KUJUBU, D.A. & HERSCHMAN, H.R. (1992). Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem., 267, 7991-7994.
27. LIU, X.H., YAO, S., KIRSCHENBAUM, A. & LEVINE, A.C. (1998). NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58, 4245-4249.
28. LU, X., XIE, W., REED, D., BRADSHAW, W.S. & SIMMONS, D.L. (1995). Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 92, 7961-7965.
29. MARICIC, N., EHRLICH, K., SCHULIGOI, R. & PESKAR, B.M. (1999). Cyclooxygenase-2-derived prostaglandins interact with nitric oxide and afferent neurons in the maintenance of rat gastric mucosal integrity. Gastroenterology, 116, A280-281.
30. MARICIC, N., EHRLICH, K., SCHULIGOI, R., RESPONDEK, M. & PESKAR, B.M. (1998). Cyclooxygenase-2-derived prostaglandins contribute to mucosal resistance to ischemia/reperfusion injury in the rat stomach. Gastroenterology, 114, A215.
31. MASFERRER, J.L., ZWEIFEL, B.S., MANNING, P.T., HAUSER, S.D., LEAHY, K.M., SMITH, W.G., ISAKSON, P.C. & SEIBERT, K. (1994). Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A., 91, 3228-3232.
32. MEADE, E.A., SMITH, W.L. & DE WITT, D.L. (1993). Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem., 268, 6610-6614.
33. MITCHELL, J.A., LARKIN, S. & WILLIAMS, T.J. (1995). Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol., 50, 1535-1542.
34. MIZUNO, H., SAKAMOTO, C., MATSUDA, K., WADA, K., UCHIDA, T., NOGUCHI, H., AKAMATSU, T. & KASUGA, M. (1997). Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology, 112, 387-397.
35. NOWAK, J. & WENNMALM, A. (1979). A study on the role of endogenous prostaglandins in the development of exercise-induced and post-occlusive hyperemia in human limbs. Acta Physiol. Scand., 106, 365-369.
36. O'NEILL, G.P. & FORD-HUTCHINSON, A.W. (1993). Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett., 330, 156-160.
37. 2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion. Am. J. Surg., 157, 562-565.
38. POULIOT, M., GILBERT, C., BORGEAT, P., POUBELLE, P.E., BOURGOIN, S., CREMINON, C., MACLOUF, J., MCCOLL, S.R. & NACCACHE, P.H. (1998). Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J., 612, 1109-1123.
39. RAZ, A., WYCHE, A. & NEEDLEMAN, P. (1989). Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc. Natl. Acad. Sci. U.S.A., 86, 1657-1661.
40. REUTER, B.K., ASFAHA, S., BURET, A., SHARKEY, K.A. & WALLACE, J.L. (1996). Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest., 98, 2076-2085.
41. RIENDEAU, D., PERCIVAL, M.D., BOYCE, S., BRIDEAU, C., CHARLESON, S., CROMLISH, W., ETHIER, D., EVANS, J., FALGUEYRET, J.P., FORD-HUTCHINSON, A.W., GORDON, R., GREIG, G., GRESSER, M., GUAY, J., KARGMAN, S., LÉGER, S., MANCINI, J.A., O'NEILL, G., OUELLET, M., RODGER, I.W., THÉRIEN, M., WANG, Z., WEBB, J.K., WONG, E., XU, L., YOUNG, R.N., ZAMBONI, R., PRASIT, P. & CHAN, C.C. (1997). Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol., 121, 105-117.
42. ROBERT, A. (1979). Cytoprotection by prostaglandins. Gastroenterology, 77, 761-767.
43. SCHMASSMANN, A., PESKAR, B.M., STETTLER, C., NETZER, P., STROFF, T., FLOGERZI, P. & HALTER, F. (1998). Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br. J. Pharmacol., 123, 795-804.
44. SCHMEDTJE, Jr, J.F., JI, Y.S., LIU, W.L., DUBOIS, R.N. & RUNGE, M.S. (1997). Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem., 272, 601-608.
45. SOLL, A.H., WEINSTEIN, W.M., KURATA, J. & MCCARTHY, D. (1991). Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann. Intern. Med., 114, 307-319.
46. STROFF, T., PLATE, S., EBRAHIM, J.S., EHRLICH, K., RESPONDEK, M. & PESKAR, B.M. (1996). Tachykinin-induced increase in gastric mucosal resistance: role of afferent neurons, CGRP, and NO. Am. J. Physiol., 271, G1017-G1027.
47. TOMLINSON, A., APPLETON, I., MOORE, A.R., GILROY, D.W., WILLIS, D., MITCHELL, J.A. & WILLOUGHBY, D.A. (1994). Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br. J. Pharmacol., 113, 693-698.
48. VANE, J.R. & BOTTING, R.M. (1995). New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res., 44, 1-10.
49. WHITTLE, B.J.R. (1981). Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 80, 94-98.
50. WONG, K. & FREUND, K. (1981). Inhibition of the n-formylmethionyl-leucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can. J. Physiol. Pharmacol., 59, 915-920.
51. 4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology, 99, 1358-1363.